OBJECTIVE: To analyse the association of direct and indirect costs in patients with medically unexplained symptoms (MUS) with somatic symptom severity (SSS). METHODS: A cross-sectional cost analysis for retrospective 6 months was conducted in 294 primary care patients with MUS. Health care utilisation and loss of productivity were measured by questionnaires. SSS was measured using the "Patient Health Questionnaire 15" (PHQ-15). Direct and indirect costs and the association of costs with SSS were analysed via multiple linear regression analysis. RESULTS: Patients with MUS had average 6-month direct costs of 1098 EUR and indirect costs of 7645 EUR. For direct costs, outpatient physician visits were the most expensive single cost category (36%), followed by pharmaceuticals (25%) and hospital stays (19%). Indirect costs were predominantly caused by productivity reduction at work (56%) followed by early retirement (29%) and acute sickness absence (14%). As compared to mild SSS, moderate SSS was not significantly associated with direct, but with indirect costs (+2948 EUR; p<.001); severe SSS was associated with increased direct cost (+658 EUR; p=.001) and increased indirect costs (+4630 EUR; p<.001). Age was positively associated with direct cost (+15 EUR for each additional year; p=.015) as well as indirect cost (+104 EUR for each additional year; p<.001). CONCLUSIONS: MUS are associated with relevant direct and even much higher indirect costs that strongly depend on SSS.
OBJECTIVE: To analyse the association of direct and indirect costs in patients with medically unexplained symptoms (MUS) with somatic symptom severity (SSS). METHODS: A cross-sectional cost analysis for retrospective 6 months was conducted in 294 primary care patients with MUS. Health care utilisation and loss of productivity were measured by questionnaires. SSS was measured using the "Patient Health Questionnaire 15" (PHQ-15). Direct and indirect costs and the association of costs with SSS were analysed via multiple linear regression analysis. RESULTS:Patients with MUS had average 6-month direct costs of 1098 EUR and indirect costs of 7645 EUR. For direct costs, outpatient physician visits were the most expensive single cost category (36%), followed by pharmaceuticals (25%) and hospital stays (19%). Indirect costs were predominantly caused by productivity reduction at work (56%) followed by early retirement (29%) and acute sickness absence (14%). As compared to mild SSS, moderate SSS was not significantly associated with direct, but with indirect costs (+2948 EUR; p<.001); severe SSS was associated with increased direct cost (+658 EUR; p=.001) and increased indirect costs (+4630 EUR; p<.001). Age was positively associated with direct cost (+15 EUR for each additional year; p=.015) as well as indirect cost (+104 EUR for each additional year; p<.001). CONCLUSIONS: MUS are associated with relevant direct and even much higher indirect costs that strongly depend on SSS.
Authors: Ather Ali; Theresa R Weiss; Anne Dutton; Douglas McKee; Kim D Jones; Susmita Kashikar-Zuck; Wendy K Silverman; Eugene D Shapiro Journal: J Pediatr Date: 2017-01-12 Impact factor: 4.406
Authors: Azucena Maribel Rodriguez González; José Manuel Ramírez Aranda; Homero de Los Santos Reséndiz; María Yolanda Lara Duarte; Santiago Oscar Pazaran Zanella; Jafet Felipe Méndez López; Issa Gil Alfaro; Félix Gilberto Islas Ruz; Gloria Navarrete Floriano; Edith Guillen Salomón; Obdulia Texon Fernández; Silvia Cruz Duarte; Juan Carlos Romo Salazar; Claudia Elsa Pérez Ruiz; Sara de Jesús López Salas; Lizbeth Benítez Amaya; Javier Nahum Zapata Gallardo Journal: Colomb Med (Cali) Date: 2016-09-30
Authors: Jonna F van Eck van der Sluijs; Margreet Ten Have; Ron de Graaf; Cees A Th Rijnders; Harm W J van Marwijk; Christina M van der Feltz-Cornelis Journal: Front Psychiatry Date: 2018-11-20 Impact factor: 4.157
Authors: Margreet S H Wortman; Joran Lokkerbol; Johannes C van der Wouden; Bart Visser; Henriëtte E van der Horst; Tim C Olde Hartman Journal: PLoS One Date: 2018-10-15 Impact factor: 3.240
Authors: Katja Loengaard; Jakob Bue Bjorner; Per Klausen Fink; Hermann Burr; Reiner Rugulies Journal: BMC Public Health Date: 2015-09-02 Impact factor: 3.295
Authors: Madelon den Boeft; Jos W R Twisk; Trynke Hoekstra; Berend Terluin; Brenda W J H Penninx; Johannes C van der Wouden; Mattijs E Numans; Henriette E van der Horst Journal: BMC Fam Pract Date: 2016-04-14 Impact factor: 2.497